Article
AstraZeneca to invest $245 mln in Cellectis to boost gene therapy prospects
Rating:
0.0
Views:
55
Likes:
1
Library:
1
AstraZeneca said on Wednesday it would invest $245 million in French biotechnology company Cellectis in a deal aimed at speeding up the development of therapeutics in areas including oncology, immunology and rare diseases.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value